MTSI dropped 6.8% on Friday and is down 5.5% on the week — a sharp reversal after a 37% gain in just the past month. That tension is the setup: a stock that just delivered one of its best earnings reactions in recent memory, now shedding altitude fast, while analysts and institutional holders are still positioned firmly on the bull side.
The earnings catalyst is worth understanding first. When MACOM reported in early May, the stock jumped 16% on the day and extended to nearly 24% over the following five sessions — a standout reaction even within a strong semiconductor tape. Next results are due August 6. In the three weeks since that print, the stock climbed another leg higher. The pullback this week looks like exhaust after that run rather than a fundamental turn, but the pace of the decline — the steepest single-day move in that five-week window — is worth monitoring.
Options positioning tells a distinctly bullish story. The put/call ratio has collapsed to 0.24, well below its 20-day average of 0.30 and near the lower end of the 52-week range (0.07–0.73). Call activity is dominating. That is not the profile of a market bracing for further downside; it reads more like traders holding or adding upside exposure even as the stock corrects. The short side is similarly unalarmed. Short interest rose 38% in the past week to 3.9% of the free float — notable acceleration, but from a low base, and still modest in absolute terms. Borrowing costs remain negligible at 0.56%. Availability in the lending market is extremely loose at 1,743% of current short interest, meaning there is no constraint whatsoever on anyone wanting to initiate or add to a short position. The borrow market offers no squeeze dynamic at this level.
The Street came out of May earnings in near-unison. Multiple firms raised targets sharply on May 8 — Evercore ISI moved to $427 from $275, Barclays lifted twice (first to $400, then to $450 just this past week), Needham went to $400 from $250, and Truist to $375 from $261. JPMorgan, staying Neutral, still moved its target from $240 to $345. The consensus mean target is $393, roughly 8% above Friday's close of $364.64. Barclays' fresh $450 target, raised on May 22, is the most aggressive. The analyst divergence is not bull-vs-bear on direction — it is bull-vs-neutral on magnitude. The factor score on analyst recommendation divergence ranks in the 90th percentile of the universe, flagging just how lopsidedly constructive the analyst community is. EPS momentum scores in the 83rd percentile on a 30-day basis. Valuation is the clear friction point: the forward P/E has expanded to 67.9 — up 12 points in 30 days — and EV/EBITDA runs at 61.7x, expensive by almost any framework. The bull case rests on data center and defence demand plus 5G and LEO satellite optionality. The bear case centres on data centre concentration risk, integration drag from acquisitions, and margin cyclicality.
Institutional holders are generally sitting tight. FMR (Fidelity) holds 13.9% and added over 4 million shares in the most recent reporting period, making it comfortably the largest holder. BlackRock added another 1 million shares to reach 11.2%. Neither is trimming. The CFO, John F. Kober, sold roughly $1.5 million in aggregate on May 18 across multiple tranches — all at prices in the $352–$369 range, close to where the stock trades now. The significance score on those transactions is low (2/10), consistent with routine plan-driven selling rather than a discretionary signal. Net insider activity over 90 days is modestly positive on shares, though the dominant recent flow has been CFO sales.
The question heading into August earnings is whether the valuation expansion of the past month holds at 68x forward earnings as the stock digests its post-results rally, or whether the next catalyst is needed to justify a price that has effectively repriced an entirely new growth regime into the multiple.
See the live data behind this article on ORTEX.
Open MTSI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
